Engineered protein complex could help immunotherapies target hard-to-treat neuroblastoma

Researchers from Children’s Hospital of Philadelphia (CHOP) have developed a method to help cancer immunotherapies reach otherwise “invisible” tumors by helping guide therapies to their appropriate targets. This could be particularly useful for very difficult-to-treat tumors like neuroblastoma. The findings appear in Science Advances.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup